1. Home
  2. HOVR vs ATOS Comparison

HOVR vs ATOS Comparison

Compare HOVR & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Horizon Aircraft Ltd.

HOVR

New Horizon Aircraft Ltd.

HOLD

Current Price

$1.77

Market Cap

80.5M

Sector

Finance

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$5.28

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOVR
ATOS
Founded
2013
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.5M
83.3M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
HOVR
ATOS
Price
$1.77
$5.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$6.50
$31.67
AVG Volume (30 Days)
1.4M
197.0K
Earning Date
01-14-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$55.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$4.91
52 Week High
$4.18
$19.35

Technical Indicators

Market Signals
Indicator
HOVR
ATOS
Relative Strength Index (RSI) 42.86 89.90
Support Level $1.76 $4.91
Resistance Level $1.95 $7.56
Average True Range (ATR) 0.24 0.31
MACD -0.07 0.57
Stochastic Oscillator 7.32 67.40

Price Performance

Historical Comparison
HOVR
ATOS

About HOVR New Horizon Aircraft Ltd.

New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: